CA1030953A - Psychopharmacologically active peptides - Google Patents

Psychopharmacologically active peptides

Info

Publication number
CA1030953A
CA1030953A CA164,274A CA164274A CA1030953A CA 1030953 A CA1030953 A CA 1030953A CA 164274 A CA164274 A CA 164274A CA 1030953 A CA1030953 A CA 1030953A
Authority
CA
Canada
Prior art keywords
active peptides
psychopharmacologically
psychopharmacologically active
peptides
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA164,274A
Other languages
English (en)
French (fr)
Other versions
CA164274S (en
Inventor
Hendrik M. Greven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzona Inc
Original Assignee
Akzona Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzona Inc filed Critical Akzona Inc
Application granted granted Critical
Publication of CA1030953A publication Critical patent/CA1030953A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA164,274A 1972-02-22 1973-02-21 Psychopharmacologically active peptides Expired CA1030953A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7202278A NL7202278A (enExample) 1972-02-22 1972-02-22

Publications (1)

Publication Number Publication Date
CA1030953A true CA1030953A (en) 1978-05-09

Family

ID=19815436

Family Applications (1)

Application Number Title Priority Date Filing Date
CA164,274A Expired CA1030953A (en) 1972-02-22 1973-02-21 Psychopharmacologically active peptides

Country Status (12)

Country Link
US (1) US3853836A (enExample)
JP (1) JPS4896586A (enExample)
AU (1) AU471298B2 (enExample)
BE (1) BE795788A (enExample)
CA (1) CA1030953A (enExample)
CH (1) CH585192A5 (enExample)
DE (1) DE2308362A1 (enExample)
FR (1) FR2181759B1 (enExample)
GB (1) GB1416271A (enExample)
HU (1) HU168890B (enExample)
NL (1) NL7202278A (enExample)
ZA (1) ZA73839B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
NZ214543A (en) * 1984-12-14 1990-03-27 Australian Commercial Research Amino acid and peptide derivatives that inhibit human leucocytic elastase enzyme (hle)
US5462927A (en) * 1985-04-30 1995-10-31 The Administrators Of The Tulane Educational Fund Peptides aiding nerve regeneration
JP2525798B2 (ja) * 1987-03-12 1996-08-21 第一製薬株式会社 ペプチド誘導体
WO1993000922A1 (en) * 1991-07-01 1993-01-21 The Administrators Of The Tulane Educational Fund Peptides aiding nerve regeneration
US7176279B2 (en) * 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
CA2419285C (en) * 2000-08-25 2011-08-02 Research Corporation Technologies, Inc. New uses for amino acid anticonvulsants
AU2002322466B2 (en) * 2001-07-11 2007-08-30 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
AU2005231034B2 (en) * 2004-04-08 2010-04-08 Telsar Pharma Inc. Compound WS727713
MXPA06011521A (es) 2004-04-08 2007-03-21 Astellas Pharma Inc Compuesto ws 727713.
US20130059914A1 (en) 2010-04-21 2013-03-07 Signature Therapeutics, Inc. Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
US11590209B2 (en) 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension
AU2021382158C1 (en) * 2020-11-18 2026-05-07 Definium Therapeutics US, Inc. Mdma prodrugs to assist psychotherapy
KR20230174213A (ko) 2021-03-09 2023-12-27 엔사이스 바이오사이언시즈 인크. 나파모스타트의 변형된 방출 조성물 및 그의 사용 방법
CN117715632A (zh) 2021-03-09 2024-03-15 恩赛斯生物科学股份有限公司 包含酶可裂解的前药和萘莫司他的组合物及其使用方法
MX2024003466A (es) 2021-09-29 2024-06-04 Ensysce Biosciences Inc Profarmacos de metadona escindibles por enzimas y metodos de uso de los mismos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1302396A (fr) * 1961-03-10 1962-08-31 Ciba Geigy Procédés de préparation de nouveaux heptapeptides de formule l-alpha-[mercaptoalcoyl (inférieur)]-alpha-amino-acétyl-l-glutaminyl-l-histidyl-l-phényl alanyl-l-alpha-[amino-alcoyl (inférieur)]-alpha-amino-acétyl-l-tryptophyl glycine
NL278010A (enExample) * 1961-05-04 1900-01-01
NL6509727A (enExample) * 1965-07-28 1967-01-30
GB1230472A (enExample) * 1967-07-10 1971-05-05

Also Published As

Publication number Publication date
AU5197973A (en) 1974-08-08
CH585192A5 (enExample) 1977-02-28
HU168890B (enExample) 1976-08-28
US3853836A (en) 1974-12-10
JPS4896586A (enExample) 1973-12-10
FR2181759B1 (enExample) 1976-09-03
AU471298B2 (en) 1976-04-15
GB1416271A (en) 1975-12-03
FR2181759A1 (enExample) 1973-12-07
NL7202278A (enExample) 1973-08-24
BE795788A (nl) 1973-08-22
DE2308362A1 (de) 1973-09-06
ZA73839B (en) 1973-11-28

Similar Documents

Publication Publication Date Title
AU471298B2 (en) Psychopharmacologically active peptides
CA1025440A (en) Psychopharmacologically active peptides
CA968825A (en) Packing
AU471401B2 (en) Sedative peptides
AU465548B2 (en) Psychopharmacological peptides
AU470908B2 (en) Psychopharmacologically active peptides
AU475143B2 (en) electrode
AU471618B2 (en) Psychopharma cologically active peptides
CA988169A (en) Electrode
CA1010022A (en) Psychopharmacological peptides
AU451929B2 (en) Electrode
AU470906B2 (en) Psychopharmacological peptides
AU481531B2 (en) Therapeutically active aryldiamides
AU482511B2 (en) Insecticide
AU482278B2 (en) Insecticide
AU485483B2 (en) Terminating ribbon-conductors
AU478476B2 (en) Improved rollerskate
CA914157A (en) Peptides
AU3935172A (en) Tripeptide
CA890416A (en) Synthetic peptides
CA897152A (en) Protein
CA904270A (en) Protein
CA893094A (en) N-(5-nitro-2-furfurylidene)-3-amino-2-oxazolidone preparations
CA906656A (en) Active memory
CA890195A (en) Slide-spark electrode system